Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ejphar.2021.173854 http://scihub22266oqcxt.onion/10.1016/j.ejphar.2021.173854 33428898!7836247!33428898     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Pharmacol 2021 ; 894 (ä): 173854 Nephropedia Template TP {{tp|p=33428898|t=2021. Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic |pdf=|usr=}}{{33428898}} gab.com Text Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic JO: Eur J Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33428898 #FOAvip The current outbreak of novel COVID-19 challenges the development of an efficient treatment plan as soon as possible. Several promising treatment options stand out as potential therapy of COVID-19, including plasma-derived drugs, monoclonal antibodies, antivirals, antimalarial, cell therapy, and corticosteroids. Dexamethasone an approved corticosteroid medication, acting as an anti-inflammatory and immunosuppressant agent. In the current pandemic, dexamethasone is declared a "major development" in the fight against COVID-19. Steroidal dexamethasone was presented as the recent advancement that significantly reduces the mortality rate among severe COVID-19 cases. This review summarizes the preliminary opinion about the dexamethasone outbreak, therapeutic potential, risks, and strategies during the COVID-19 pandemic. Twit Text FOAVip Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic ????Eur J Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33428898 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33428898 #FOAvip English Wikipedia <ref>{{Cite pmid|33428898}}</ref> Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic #MMPMID33428898 Noreen S; Maqbool I; Madni A Eur J Pharmacol 2021[Mar]; 894 (ä): 173854 PMID33428898show ga The current outbreak of novel COVID-19 challenges the development of an efficient treatment plan as soon as possible. Several promising treatment options stand out as potential therapy of COVID-19, including plasma-derived drugs, monoclonal antibodies, antivirals, antimalarial, cell therapy, and corticosteroids. Dexamethasone an approved corticosteroid medication, acting as an anti-inflammatory and immunosuppressant agent. In the current pandemic, dexamethasone is declared a "major development" in the fight against COVID-19. Steroidal dexamethasone was presented as the recent advancement that significantly reduces the mortality rate among severe COVID-19 cases. This review summarizes the preliminary opinion about the dexamethasone outbreak, therapeutic potential, risks, and strategies during the COVID-19 pandemic. |*COVID-19 Drug Treatment[MESH] |*Pandemics[MESH] |Anti-Inflammatory Agents/adverse effects/*therapeutic use[MESH] |COVID-19/complications/mortality[MESH] |Dexamethasone/adverse effects/*therapeutic use[MESH] |Humans[MESH] |Immunosuppressive Agents/adverse effects/*therapeutic use[MESH]Dexamethasone: Therapeutic potential, risks, and future projection dur(epmc).pdf DeepDyve Pubget Overpricing